학술논문
Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
Document Type
article
Author
Source
Clinical Case Reports, Vol 8, Iss 10, Pp 2069-2070 (2020)
Subject
Language
English
ISSN
2050-0904
Abstract
Abstract Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.